FDA

Quite a bit of psych related updates in today's ASHP update

Hello all! Thought I would share in case some of you missed these updates. Enjoy and Happy Tuesday! Andy ---------- Forwarded message ---------- From: ashp_daily_briefing < ashp_daily_briefing@ashp.custombriefings.com > Date: Tue, Mar ...

[World Report] FDA rejects novel diabetes drug over safety fears

The US Food and Drug Administration has said that it will not approve first-in-class diabetes drug dapaglifozin until more trial data become available. Talha Khan Burki reports.

Rosiglitazone, Myocardial Ischemic Risk, and Recent Regulatory Actions

OBJECTIVE: To review the evidence surrounding rosiglitazone and ischemic cardiovascular risk and discuss the Food and Drug Administration (FDA) decision to revise safety information and restrict access to the drug.

anyone have experience with high dose adderall?

Has anyone had experience with doses of amphetamine/dextroamphetamine above FDA max of 60mg daily?   This is regarding trial of 80mg daily dosage for a 29 yo medically healthy female with ADHD.   Thank you for any input. ...

FDA is sued for allegedly violating privacy of employees

Six current and former employees of the US Food and Drug Administration (FDA) have sued that agency for allegedly violating their right to privacy by secretly monitoring their personal email...

citalopram pkg. insert change leading to decompensation

Would a decompensation related to recent package insert change be reportable to FDA via MedWatch?  I think it’s important they be aware of the damage that can be done due to the hypervigilance of the FDA and overreactions the warnings can ...

FDA faces barrage of criticism over plans to assess safety of supplements

A plan by the US Food and Drug Administration to assess the safety of nutritional supplements is facing criticism for being not enough to protect the public from harm.

&quot;new&quot; alliance- Just FYI

  The Food and Drug Administration (FDA) invites you to partner with and become a member of the Global Alliance of Drug Information Specialists (GADIS).  We recognize your contributions in clinical practice and request your ...